| Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment (NCT05437120) | Vertex Pharmaceuticals Incorporated | 2022-07-22 |
| Video Telehealth Exercise Training in Cystic Fibrosis (NCT04680403) | University of Alabama at Birmingham | 2022-07-01 |
| Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF (NCT05276960) | Hospital Infantil de Mexico Federico Gomez | 2022-06-22 |
| Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age (NCT05422222) | Vertex Pharmaceuticals Incorporated | 2022-06-21 |
| Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection (NCT05010577) | BiomX, Inc. | 2022-06-21 |
| COVID-19 Antibody Responses in Cystic Fibrosis (NCT05614336) | Hospices Civils de Lyon | 2022-06-15 |
| Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis (NCT05314764) | Hartford Hospital | 2022-06-01 |
| Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation (NCT05274269) | Vertex Pharmaceuticals Incorporated | 2022-05-09 |
| Cystic Fibrosis and Frailtyh What's in Common? (NCT06020547) | Federico II University | 2022-05-01 |
| BEGIN Novel ImagiNG Biomarkers (NCT05517655) | Children's Hospital Medical Center, Cincinnati | 2022-05-01 |
| Investigation of Relationship Between Vascular Functions, Exercise Capacity, and Respiratory Functions in CF (NCT04259983) | Hacettepe University | 2022-04-11 |
| Role of Toilet Bronchoscopy in RICU (NCT04798118) | Assiut University | 2022-04-01 |
| Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior (NCT05699148) | Nottingham University Hospitals NHS Trust | 2022-04-01 |
| Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases (NCT04825067) | Institute of Bioengineering and Bioimaging (IBB) | 2022-04-01 |
| Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic Fibrosis (NCT05249322) | Hospices Civils de Lyon | 2022-03-31 |
| Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies (NCT05100823) | University Hospital, Montpellier | 2022-03-30 |
| TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era (NCT05752019) | Erasmus Medical Center | 2022-03-21 |
| Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine (NCT04137133) | University Hospital, Brest | 2022-03-21 |
| Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis (NCT05239611) | University of Kansas Medical Center | 2022-03-15 |
| Description of the Short-term Effects of KAFTRIO® by Continuous Monitoring With the PHEAL-CR-K Application in Real Life in Patients With Cystic Fibrosis Eligible for KAFTRIO® Treatment (NCT05295524) | Hopital Foch | 2022-03-14 |
| A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis (NCT05095246) | Krystal Biotech, Inc. | 2022-03-08 |
| Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis (NCT05225805) | Nabriva Therapeutics AG | 2022-03-01 |
| A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF (NCT05251467) | Nottingham University Hospitals NHS Trust | 2022-02-28 |
| Trikafta/Kaftrio and Pseudomonas Aeruginosa (NCT05675592) | Ospedale San Raffaele | 2022-02-22 |
| Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240 (NCT03435939) | University of Kansas Medical Center | 2022-02-15 |
| Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function (NCT04530383) | University of Kansas Medical Center | 2022-02-14 |
| COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF) (NCT05217784) | Rabin Medical Center | 2022-01-25 |
| Pilocarpine Microneedles for Sweat Induction (PMN-SI) (NCT04732195) | Emory University | 2022-01-20 |
| Perceptions of the CF Screening Protocol Incorporating NGS (NCT06299566) | King's College London | 2022-01-19 |
| Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older (NCT05153317) | Vertex Pharmaceuticals Incorporated | 2022-01-17 |
| A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF) (NCT05111145) | Vertex Pharmaceuticals Incorporated | 2022-01-14 |
| Airway Microbiome of Cystic Fibrosis Patients (NCT06057558) | University Hospital, Antwerp | 2022-01-01 |
| PEP and O-PEP Device for Nebulization in Cystic Fibrosis (NCT06964074) | National Institute for Tuberculosis and Lung Diseases, Poland | 2022-01-01 |
| Thermic Effect of Feeding in Cystic Fibrosis (NCT03931252) | Virginia Commonwealth University | 2022-01-01 |
| Renal Impact of KAFTRIO in Mucoviscidose Population (NCT06197490) | Hospices Civils de Lyon | 2022-01-01 |
| COVID-19 Antibody Responses In Cystic Fibrosis (NCT05158829) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2022-01-01 |
| Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes. (NCT05377502) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-12-15 |
| Lung Transplant READY Pilot Study (NCT05135156) | University of Washington | 2021-12-06 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis (NCT05090904) | Insmed Incorporated | 2021-11-30 |
| Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis (NCT05099939) | Institut de Recherches Cliniques de Montreal | 2021-11-25 |
| Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis (NCT05195216) | Elif Kabasakal | 2021-11-20 |
| COVID-19 Antibody Responses In Cystic Fibrosis (NCT04863573) | Queen's University, Belfast | 2021-11-19 |
| Trikafta Exercise Study in Cystic Fibrosis (NCT05279040) | University of British Columbia | 2021-11-10 |
| Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus (NCT05101915) | Papworth Hospital NHS Foundation Trust | 2021-11-01 |
| Ketone Supplementation in Cystic Fibrosis (NCT04938726) | University of Alabama at Birmingham | 2021-11-01 |
| Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF (NCT05200429) | University of British Columbia | 2021-11-01 |
| A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation (NCT05076149) | Vertex Pharmaceuticals Incorporated | 2021-10-27 |
| Remotely Supervised Exercise for Adults With Cystic Fibrosis (NCT05173194) | Universidad Europea de Madrid | 2021-10-26 |
| NETwork of Linoleic Acid Supplementation in Cystic Fibrosis (NCT04531410) | Karolinska Institutet | 2021-10-25 |
| A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis (NCT04519853) | Boston Children's Hospital | 2021-10-25 |
| Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric Intake (NCT06072365) | University Hospital, Toulouse | 2021-10-21 |
| Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs (NCT04930289) | Paragonix Technologies | 2021-10-15 |
| Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon (NCT05069597) | AbbVie | 2021-10-14 |
| The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis (NCT05944367) | Papworth Hospital NHS Foundation Trust | 2021-10-13 |
| A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF) (NCT04969224) | Vertex Pharmaceuticals Incorporated | 2021-10-12 |
| CFTR Modulators and Gastrointestinal Complications (NCT05253859) | Nottingham University Hospitals NHS Trust | 2021-10-01 |
| Prospective Study of Pregnancy in Women With Cystic Fibrosis (NCT04828382) | Amalia Magaret | 2021-09-30 |
| A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) (NCT05033080) | Vertex Pharmaceuticals Incorporated | 2021-09-14 |
| Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor (NCT05937815) | University Hospital, Bordeaux | 2021-09-13 |
| COVID-19 Antibody Responses in Cystic Fibrosis (NCT05052294) | University Hospital, Motol | 2021-09-13 |
| Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD (NCT04921332) | Erica Osborn | 2021-09-07 |
| Markers of Osteoporosis in Cystic Fibrosis (NCT03921060) | University of Texas Southwestern Medical Center | 2021-09-02 |
| A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (NCT03698448) | AlgiPharma AS | 2021-09-01 |
| Training in Shared Decision-making of Cystic Fibrosis Centers Competences in the Treatment of CF Related Diabetes in Adult Patients (NCT04891159) | Hospices Civils de Lyon | 2021-09-01 |
| COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF (NCT05054582) | Medical University Innsbruck | 2021-09-01 |
| Safety and Feasibility of High-intensity Interval Training Program in CF Patients (NCT04888767) | Fondation Ildys | 2021-09-01 |
| COVID-19 Antibody Responses in Cystic Fibrosis (NCT04992234) | Vastra Gotaland Region | 2021-08-31 |
| Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis (NCT04451213) | Cardiff and Vale University Health Board | 2021-08-23 |
| Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis (NCT04644471) | Assistance Publique - Hôpitaux de Paris | 2021-08-05 |
| Cell Content of Sputum Induced by Hypertonic Saline in Adolescents With Cystic Fibrosis (NCT06909903) | Assistance Publique Hopitaux De Marseille | 2021-07-20 |
| GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance (NCT04731272) | University of Pennsylvania | 2021-07-16 |
| Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters (NCT05029817) | Hadassah Medical Organization | 2021-07-15 |
| Clinical Effort Against Smoke Exposure in Cystic Fibrosis (NCT04777344) | University of Alabama at Birmingham | 2021-07-08 |
| Cystic Fibrosis Blood Neutrophils (NCT04970225) | Assistance Publique - Hôpitaux de Paris | 2021-07-08 |
| MyVoice:CF Decision Aid for Women With Cystic Fibrosis (NCT04825236) | University of Pittsburgh | 2021-07-01 |
| Pharmacokinetics of Omadacycline in Cystic Fibrosis (NCT04460586) | Paul Beringer | 2021-07-01 |
| Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases (NCT04857814) | University of Alberta | 2021-07-01 |
| A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis (NCT04923464) | Vertex Pharmaceuticals Incorporated | 2021-06-30 |
| The PROMISE Pediatric Study 6 to 11 Years Old (NCT04613128) | Nicole Hamblett | 2021-06-11 |
| A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects (NCT04926701) | Enterprise Therapeutics Ltd | 2021-06-11 |
| MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis (NCT04620096) | University of Washington | 2021-06-01 |
| Monocytes as Predictors of Cystic Fibrosis-related Bone Disease (NCT04877223) | Université de Reims Champagne-Ardenne | 2021-06-01 |
| General Health, Attitudes, and Activity in Self-directed Exercise in Patients With Cystic Fibrosis (GAINS-CF) (NCT04882267) | University of Virginia | 2021-05-31 |
| Covid-19 Antibody Responses in Cystic Fibrosis (NCT05012306) | Universitätsklinikum Köln | 2021-05-28 |
| HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy (NCT04798014) | Indiana University | 2021-05-26 |
| COVID-19 Antibody Responses In Cystic Fibrosis (NCT04904445) | Erasmus Medical Center | 2021-05-21 |
| Case-control Study of Sleep Disorders in Children With Cystic Fibrosis (NCT04847882) | University Hospital, Strasbourg, France | 2021-05-20 |
| Use of Capnography for the Follow-up of Cystic Fibrosis Children (NCT04814797) | Central Hospital, Nancy, France | 2021-05-05 |
| Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF (NCT04809207) | Johns Hopkins University | 2021-05-01 |
| Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials (NCT04580368) | Children's Hospital Medical Center, Cincinnati | 2021-05-01 |
| Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections (NCT04884308) | Johns Hopkins University | 2021-04-28 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection (NCT04966234) | Bambino Gesù Hospital and Research Institute | 2021-04-22 |
| The Impact Of A Tele-Exercise Program For Children With Cystic Fibrosis During The Covid-19 Pandemic On Quality Of Life (NCT05481190) | Ondokuz Mayıs University | 2021-04-01 |
| An Assistive Powered Wheelchair: Stage 2 Trial (NCT05292690) | East Kent Hospitals University NHS Foundation Trust | 2021-03-29 |
| CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) (NCT04684641) | Yale University | 2021-03-29 |
| Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance in Patients With Cystic Fibrosis (NCT04803643) | Gazi University | 2021-03-16 |
| Concerns of Children Whose Parents Have Cystic Fibrosis (NCT04702386) | Assistance Publique - Hôpitaux de Paris | 2021-02-18 |
| Regional Phenotyping of CF and Non-CF Bronchiectasis (NCT04793867) | Children's Hospital Medical Center, Cincinnati | 2021-02-08 |
| CFTR Related Pancreatitis Study (NCT04274413) | The Hospital for Sick Children | 2021-02-01 |
| Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis (NCT06057714) | University of North Carolina, Chapel Hill | 2021-01-20 |